Renaissance Technologies’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.9M | Buy |
+263,153
| New | +$20.3M | 0.03% | 672 |
|
|
2025
Q4 | – | Sell |
-160,900
| Closed | -$12.1M | – | 3327 |
|
|
2025
Q3 | $12.1M | Sell |
160,900
-421,953
| -72% | -$28.9M | 0.02% | 994 |
|
|
2025
Q2 | $40.2M | Buy |
582,853
+532,853
| +1,066% | +$34.9M | 0.05% | 422 |
|
|
2025
Q1 | $3.39M | Buy |
+50,000
| New | +$2.99M | 0.01% | 1671 |
|
|
2024
Q4 | – | Sell |
-967,153
| Closed | -$60.8M | – | 3633 |
|
|
2024
Q3 | $60.8M | Buy |
+967,153
| New | +$56.4M | 0.09% | 263 |
|
|
2024
Q1 | – | Sell |
-628,353
| Closed | -$49.6M | – | 3763 |
|
|
2023
Q4 | $49.6M | Buy |
+628,353
| New | +$44.7M | 0.08% | 297 |
|
|
2023
Q3 | – | Sell |
-1,425,853
| Closed | -$98.6M | – | 3726 |
|
|
2023
Q2 | $98.6M | Sell |
1,425,853
-3,644,100
| -72% | -$259M | 0.14% | 159 |
|
|
2023
Q1 | $377M | Buy |
5,069,953
+2,508,500
| +98% | +$210M | 0.5% | 23 |
|
|
2022
Q4 | $239M | Buy |
2,561,453
+715,600
| +39% | +$69.1M | 0.33% | 51 |
|
|
2022
Q3 | $176M | Sell |
1,845,853
-308,819
| -14% | -$30.6M | 0.25% | 79 |
|
|
2022
Q2 | $200M | Buy |
2,154,672
+1,379,853
| +178% | +$135M | 0.24% | 82 |
|
|
2022
Q1 | $78.4M | Buy |
774,819
+586,919
| +312% | +$61.7M | 0.09% | 233 |
|
|
2021
Q4 | $19.4M | Sell |
187,900
-126,472
| -40% | -$11.7M | 0.02% | 732 |
|
|
2021
Q3 | $26.7M | Sell |
314,372
-1,226,723
| -80% | -$103M | 0.03% | 542 |
|
|
2021
Q2 | $129M | Sell |
1,541,095
-250,358
| -14% | -$20.5M | 0.16% | 119 |
|
|
2021
Q1 | $135M | Buy |
+1,791,453
| New | +$130M | 0.17% | 116 |
|
|
2020
Q4 | – | Sell |
-1,818,923
| Closed | -$106M | – | 3431 |
|
|
2020
Q3 | $106M | Buy |
1,818,923
+739,739
| +69% | +$46M | 0.11% | 191 |
|
|
2020
Q2 | $70.1M | Sell |
1,079,184
-192,069
| -15% | -$12.1M | 0.06% | 348 |
|
|
2020
Q1 | $75.4M | Buy |
1,271,253
+1,258,200
| +9,639% | +$84M | 0.07% | 277 |
|
|
2019
Q4 | $970K | Sell |
13,053
-386,215
| -97% | -$27.1M | ﹤0.01% | 2649 |
|
|
2019
Q3 | $25.2M | Buy |
399,268
+196,615
| +97% | +$11.7M | 0.02% | 844 |
|
|
2019
Q2 | $11M | Sell |
202,653
-100,900
| -33% | -$5.43M | 0.01% | 1337 |
|
|
2019
Q1 | $16.4M | Sell |
303,553
-1,019,821
| -77% | -$62.9M | 0.01% | 1082 |
|
|
2018
Q4 | $86.7M | Buy |
+1,323,374
| New | +$98.8M | 0.09% | 250 |
|
|
2018
Q2 | – | Sell |
-1,919,505
| Closed | -$119M | – | 3301 |
|
|
2018
Q1 | $119M | Buy |
1,919,505
+30,800
| +2% | +$2.21M | 0.13% | 160 |
|
|
2017
Q4 | $137M | Buy |
+1,888,705
| New | +$137M | 0.15% | 135 |
|
|
2017
Q2 | – | Sell |
-1,414,005
| Closed | -$111M | – | 3215 |
|
|
2017
Q1 | $111M | Buy |
1,414,005
+689,500
| +95% | +$55M | 0.16% | 130 |
|
|
2016
Q4 | $57.2M | Sell |
724,505
-215,500
| -23% | -$17.4M | 0.09% | 274 |
|
|
2016
Q3 | $83.7M | Sell |
940,005
-2,902,100
| -76% | -$274M | 0.15% | 136 |
|
|
2016
Q2 | $368M | Buy |
3,842,105
+3,647,000
| +1,869% | +$363M | 0.7% | 6 |
|
|
2016
Q1 | $20.2M | Buy |
+195,105
| New | +$19M | 0.04% | 645 |
|
|
2015
Q4 | – | Sell |
-854,505
| Closed | -$82.4M | – | 3301 |
|
|
2015
Q3 | $82.4M | Buy |
+854,505
| New | +$89.8M | 0.2% | 78 |
|
|
2013
Q4 | – | Sell |
-480,305
| Closed | -$27.3M | – | 2875 |
|
|
2013
Q3 | $27.3M | Buy |
+480,305
| New | +$28.6M | 0.07% | 361 |
|
Other funds holding CVS
VCM
VPM
Renaissance Technologies's CVS Position: Q1 2026 in Review
Renaissance Technologies opened a new position in CVS Health (CVS) in Q1 2026: 263,153 shares worth $18.9M. The stake represents 0.03% of the portfolio and ranks #672 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in CVS as recently as Q3 2025.
Renaissance Technologies first reported a position in CVS in Q3 2013 and has held it in 33 quarters since. The position peaked at $377M in Q1 2023. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Renaissance Technologies held 263,153 shares of CVS Health worth $18.9M as of Q1 2026.
- CVS Health was a new Renaissance Technologies position in Q1 2026.
- CVS Health made up 0.03% of Renaissance Technologies's portfolio in Q1 2026, its #672 holding.
- Renaissance Technologies first reported a position in CVS Health in Q3 2013 and has held it in 33 quarters since.
- Renaissance Technologies's CVS Health position peaked at $377M in Q1 2023.
- 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.